- Deltex Medical Group has announced its most substantial account win in a UK NHS hospital for more than two years.

A 450 bed NHS hospital in the South-East of England has acquired six CardioQ-ODM+ monitors and an initial stock of single patient oesophageal probes for use in its peri-operative surgical care.

The hospital invested in ODM in response to clinician demand to replace the alternative technology purchased by the Trust as a result of the 2013 NHS national implementation programme for Intra-Operative Fluid Management.

The initial order was worth over £30,000 and although this does not alter full year forecasts, it does reflect a generally improving UK performance in the second half of the year to date.

At 1:08pm: [LON:DEMG] Deltex Medical Group PLC share price was +0.38p at 4.5p

Story provided by